Effects of Regular and Long-acting Insulin on Cognition and Alzheimer’s Disease Biomarkers: A Pilot Clinical Trial
Manuscript Number:
16-1256R2
Author(s):
Laura D. Baker, Erin Caulder, Brenna A. Cholerton, Amy Claxton, Suzanne Craft, Deborah Dahl, Seth Friedman, Angela Hanson, Youngkyoo Jung, Joseph Maldjian, Thomas J. Montine, Bryan Neth, Emily H. Trittschuh, Christopher Whitlow
Disclosures
Laura D. Baker
Nothing to Disclose
Erin Caulder
Nothing to Disclose
Brenna A. Cholerton
Nothing to Disclose
Amy Claxton
Nothing to Disclose
Suzanne Craft
Lecture Fees:
Received honorarium from speaking at AAIC2016 for Accera, inc.
Grants
Agency:
Eli Lilly provides placebo and open label insulin for our ongoing clinical trial RF1AG041845
Dates:
2012-present
Deborah Dahl
Nothing to Disclose
Seth Friedman
Nothing to Disclose
Angela Hanson
Nothing to Disclose
Youngkyoo Jung
Nothing to Disclose
Joseph Maldjian
Consulting Fees:
BioClinica clinical trial consultation (unrelated to subject matter or materials discussed in the manuscript)